Related Experiment Video
Updated: Dec 5, 2025

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Immobilization of arrestin-3 on different biosensor platforms for evaluating GPCR binding
Saziye Yorulmaz Avsar1, Larisa E Kapinos2, Cora-Ann Schoenenberger1
1Department of Chemistry and the Swiss Nanoscience Institute, University of Basel, 4002 Basel, Switzerland. Cornelia.Palivan@unibas.ch.
This study introduces novel biosensor assays for studying G protein-coupled receptor (GPCR) interactions. These label-free methods quantify binding affinities, revealing strong JSR1 binding to an arrestin-3 mutant.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- G protein-coupled receptors (GPCRs) are crucial drug targets, but traditional cell-based assays are complex.
- Biosensor assays offer a direct and specific alternative for monitoring GPCR-protein interactions.
Purpose of the Study:
- To develop and validate label-free biosensor assays for real-time detection of GPCR-protein binding.
- To quantify the binding kinetics between arrestin-3 proteins and the JSR1 GPCR.
Main Methods:
- Stable immobilization of histidine-tagged arrestin-3 proteins (wild type and mutants) on NTA(Ni2+)-coated sensors.
- Utilized biolayer interferometry (BLI), surface plasmon resonance (SPR), and quartz crystal microbalance with dissipation (QCM-D) for label-free detection.
- Real-time monitoring of interactions between arrestin-3 variants and JSR1 GPCR.
Main Results:
- Successfully quantified binding affinity, association, and dissociation rate constants for arrestin-3 variants with JSR1.
- Demonstrated that JSR1 exhibits the strongest binding affinity to the arrestin-3 mutant Y (R393E).
- Confirmed the utility of surface-based biosensing for label-free GPCR interaction analysis.
Conclusions:
- Introduced direct, label-free biosensor-based screening for GPCR interactions.
- These methods are adaptable for diverse GPCRs and potential drug compounds.
- Highlight the potential of arrestin mutants in GPCR research and drug discovery.
More Related Videos
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
14:43Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications
Published on: September 23, 2013